FDA Approves Eli Lilly’s GLP-1 Pill April 1, 2026 Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy. Related posts: Exposed DeepSeek Database Revealed Chat Prompts and Internal Data Identities of More Than 80 Americans Stolen for North Korean IT Worker Scams Looking to Buy a Window Air Conditioner? Read This First Brendan Carr Wants to Make All of Trump’s ‘Fake News’ Retribution Dreams Come True Post navigation Previous Previous post: Nativists Loom Over SCOTUS Birthright Citizenship Arguments Next Next post: World’s oldest known tortoise, Jonathan, dies aged 193 Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Notify me of follow-up comments by email. Notify me of new posts by email. Related News Africa: U.S. Launches ‘IP for Growth’ Programme to Boost Africa’s Creative Economy August 21, 2026 0 Africa: All of Africa Today – August 21, 2026 August 21, 2026 0
